KPMG signs deal with R&D specialist Axillium
14 Nov 2019
Big Four firm KPMG has signed an agreement with a specialist research, innovation and investment agency Axillium to support clients access research and development (R&D) grants
14 Nov 2019
Established in 2008, Axillium provides support for businesses from early stage R&D to delivery. The Midlands-based firm has supported nearly 200 organisations to move their innovation programmes forward and helped raise more than £210m in government grant funding.
The tie-up will strengthen the in-house team at KPMG which works with businesses across the UK to help them access R&D incentives and tax reliefs. The team works with clients to bid, access and manage UK government funding awards, and also to identify and form partnerships with corporates, academia and supply chains to bring new intellectual property, products and services to market.
Steven Blacker, partner in the claims and incentives group at KPMG, said: ‘R&D incentives are really important in encouraging and rewarding businesses to overcome challenges in their field.
‘Our work with Axillium is all about helping more businesses access and use the funding available to drive innovation and make those advances. Ultimately, this is in line with the government’s industrial strategy to raise total R&D investment to 2.4% of the UK economy over the next eight years and bolster science and technology-led growth.’
Will Searle, founder and director of innovation & investment at Axillium, said: ‘Working together with KPMG across the UK is a major step in Axillium’s evolution. Together we will be able to expand our innovation management support to organisations of all sizes as they develop industrial-scale innovation challenges across growing markets.’